Lipid peroxidation levels in patients with acute brucellosis

Clinical and Experimental Medicine

Volumn 5, Issue 3, 2005, Pages 117-121

  Kilic, N ^a   Ozden, M ^a   Kalkan, A ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Brucellosis; Lipid peroxidation; Malondialdehyde

Indexed keywords

DOXYCYCLINE; LIPID; MALONALDEHYDE; RIFAMPICIN; STREPTOMYCIN;

ACUTE DISEASE; ADULT; ARTICLE; BLOOD LEVEL; BRUCELLOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TARGETING; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; MEASUREMENT; PATHOGENESIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; BLOOD SEDIMENTATION; BRUCELLOSIS; C-REACTIVE PROTEIN; DOXYCYCLINE; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; PROSPECTIVE STUDIES; RIFAMPIN; STREPTOMYCIN;

EID: 27744551344     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-005-0075-2     Document Type: Article

References (22)

1. Young EJ (1995) An overview of human brucellosis. Clin Infect Dis 21:283-289
2. Corbel MJ (1997) Brucellosis and overview. Emerg Infect Dis 3:213-221
3. Young EJ (2000) Brucella species. In: Mandell GL, Bennet JE, Dolin R (eds) Principles and practice of infectious diseases. Churchill Livingstone, New York, pp 2386-2391
4. Dornand J, Gross A, Lafont V, Liautard J, Oliaro J, Liautard JP (2002) The innate immune response against brucella in humans. Vet Microbiol 90:383-394
5. Golding B, Scott DE, Scharf O, Huang LY, Zaitseva M, Lapham C, Eller N, Golding H (2001) Immunity and protection against brucella abortus. Microbes Infect 3:43-48
6. Bricker BJ, Tabatabai LB, Judge BA et al (1990) Cloning, expression and occurrence of the Brucella Cu-Zn superoxide dismutase. Infect Immun 58:2935-2939
7. Corbel MJ (1997) Recent advances in brucellosis. J Med Microbiol 6:101-103
8. Cross CE, Halliwell B, Borish ET, Pryor WA, Ames BN, Saul RL, McCord JM, Harman D (1987) Oxygen radicals and human disease (Davis Conference). Ann Int Med 107:526-545
9. Doner F, Delibas N, Dogru H, Sari I, Yorgancigil B (1999) Malondialdehyde levels and superoxide dismutase activity in experimental maxillary sinusitis. Auris Nasus Larynx 26:287-291
10. Grisham MB, Granger DN (1988) Neutrophil-mediated mucosal injury: role of reactive oxygen metabolites. Digest Dis Sci 33:6-15
11. Aghdassi E, Allard JP (2000) Breath alkanes as a marker of oxidative stress in different clinical conditions. Free Radic Biol Med 28:880-886
12. Kehrer JP (1993) Free radicals as mediators of tissue injury and disease. Crit Rev Toxicol 23:21-48
13. Satoh K (1978) Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 90:37-43
14. Yagi K (1984) Assay for blood plasma or serum. Methods Enzymol 105:328-331
15. Bankson DD, Kestin M, Rifai N (1993) Role of free radicals in cancer and atherosclerosis. Clin Lab Med 13:463-480
16. Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23:134-147
17. Parks RR, Huang CC, Haddad J Jr (1994) Evidence of oxygen radical injury in experimental otitis media. Laryngoscope 104:1389-1392
18. Motoyama T, Okamoto K, Kukita I, Hamaguchi M, Kinoshita Y, Ogawa H (2003) Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med 31:1048-1052
19. Demirdag K, Yilmaz S, Ozdarendeli A, Ozden M, Kalkan A, Kilic SS (2003) Levels of plasma malondialdehyde and erythrocyte antioxidant enzyme activities in patients with chronic hepatitis B. Hepatogastroenterology 50:766-770
20. Dabdoob WA, Abdulla ZA (2000) A panel of eight tests in the serodiagnosis and immunological evaluation of acute brucellosis. East Mediterr Health J 6:304-312
21. al-Kassab AS, Nur MA, Malik JM (1991) Evaluation of serum C-reactive protein in the diagnosis of arthritic and non-arthritic brucellosis. J Trop Med Hyg 94:92-96
22. Navarro JM, Mendoza J, Leiva J, Rodriguez-Contreras R, de la Rosa M (1990) C-reactive protein as a prognostic indicator in acute brucellosis. Diagn Microbiol Infect Dis 13:269-270